Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits

H. C. Wegener

doi:10.3920/978-90-8686-570-3

Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits

H. C. Wegener^*

^*Corresponding author af dette arbejde

Rektoratet

5 Citationer (Scopus)

Abstract

Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.

Originalsprog	Engelsk
Titel	Antimicrobial Growth Promoters : Where do we go from here?
Antal sider	6
Forlag	Wageningen Academic Publishers
Publikationsdato	1 dec. 2006
Sider	53-58
ISBN (Trykt)	9789076998879
DOI	https://doi.org/10.3920/978-90-8686-570-3
Status	Udgivet - 1 dec. 2006

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.3920/978-90-8686-570-3

Andre filer og links

Link to publication in Scopus

Citationsformater

@inbook{eab206df14214be0a4b6969e70dbb1e5,

title = "Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits",

abstract = "Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.",

keywords = "Antimicrobial growth promoters, Antimicrobial resistance, Benefits, Risks",

author = "Wegener, {H. C.}",

year = "2006",

month = dec,

day = "1",

doi = "10.3920/978-90-8686-570-3",

language = "English",

isbn = "9789076998879",

pages = "53--58",

booktitle = "Antimicrobial Growth Promoters",

publisher = "Wageningen Academic Publishers",

address = "Netherlands",

}

TY - CHAP

T1 - Use of antimicrobial growth promoters in food animals

T2 - The risks outweigh the benefits

AU - Wegener, H. C.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.

AB - Recent findings from a number of countries document that the production benefits from the use of antimicrobial growth promoters (AGPs) are minimal or absent in modern food animal production. Antimicrobial resistance is a growing public health problem. As the development of new antimicrobials has slowed down, we must preserve the power of the antimicrobials currently available. This requires that they be used prudently. The current medical treatment problems that are potentially attributable to animal use of antimicrobials are infections caused by resistant strains of enterocci, streptococci, Salmonella, Campylobacter, E. coli, etc. It is not possible to determine the exact current and potential future magnitude of the public health impact of animal use of antimicrobials compared to medical use. However, considering the very minor benefits of AGP use, the risks from their use clearly outweigh the benefits.

KW - Antimicrobial growth promoters

KW - Antimicrobial resistance

KW - Benefits

KW - Risks

UR - http://www.scopus.com/inward/record.url?scp=70349844873&partnerID=8YFLogxK

U2 - 10.3920/978-90-8686-570-3

DO - 10.3920/978-90-8686-570-3

M3 - Book chapter

AN - SCOPUS:70349844873

SN - 9789076998879

SP - 53

EP - 58

BT - Antimicrobial Growth Promoters

PB - Wageningen Academic Publishers

ER -

Use of antimicrobial growth promoters in food animals: The risks outweigh the benefits

Abstract

FN’s Verdensmål

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater